Alan B. Lancz & Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $254K | Hold |
5,250
| – | – | 0.25% | 109 |
|
2025
Q1 | $291K | Hold |
5,250
| – | – | 0.31% | 90 |
|
2024
Q4 | $253K | Sell |
5,250
-800
| -13% | -$38.6K | 0.26% | 101 |
|
2024
Q3 | $349K | Sell |
6,050
-250
| -4% | -$14.4K | 0.32% | 82 |
|
2024
Q2 | $306K | Buy |
+6,300
| New | +$306K | 0.3% | 91 |
|
2023
Q4 | $324K | Sell |
6,510
-175
| -3% | -$8.7K | 0.34% | 86 |
|
2023
Q3 | $359K | Sell |
6,685
-290
| -4% | -$15.6K | 0.41% | 75 |
|
2023
Q2 | $376K | Hold |
6,975
| – | – | 0.4% | 82 |
|
2023
Q1 | $380K | Buy |
6,975
+10
| +0.1% | +$544 | 0.39% | 82 |
|
2022
Q4 | $343K | Sell |
6,965
-400
| -5% | -$19.7K | 0.35% | 91 |
|
2022
Q3 | $280K | Hold |
7,365
| – | – | 0.33% | 92 |
|
2022
Q2 | $366K | Sell |
7,365
-400
| -5% | -$19.9K | 0.36% | 82 |
|
2022
Q1 | $399K | Hold |
7,765
| – | – | 0.35% | 83 |
|
2021
Q4 | $389K | Buy |
+7,765
| New | +$389K | 0.34% | 84 |
|